Raymond James & Associates’s FT Vest US Equity Deep Buffer ETF October DOCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-16,654
Closed -$627K 3997
2024
Q1
$627K Sell
16,654
-55,097
-77% -$2.04M ﹤0.01% 2913
2023
Q4
$2.61M Buy
71,751
+56,810
+380% +$2M ﹤0.01% 1942
2023
Q3
$517K Sell
14,941
-41,435
-73% -$1.46M ﹤0.01% 2873
2023
Q2
$1.97M Sell
56,376
-300
-0.5% -$10.1K ﹤0.01% 2067
2023
Q1
$1.86M Sell
56,676
-20,786
-27% -$669K ﹤0.01% 2078
2022
Q4
$2.43M Buy
+77,462
New +$2.41M ﹤0.01% 1871

Other funds holding DOCT

Raymond James & Associates's DOCT Position: Q2 2024 in Review

Raymond James & Associates sold out of FT Vest US Equity Deep Buffer ETF October (DOCT) in Q2 2024, closing a stake of 16,654 shares — an estimated $627K sold.

Raymond James & Associates first reported a position in DOCT in Q4 2022 and held it in 6 quarters. The position peaked at $2.61M in Q4 2023. 65 funds tracked by Wall St. Rank hold DOCT as of Q2 2024.

  • Raymond James & Associates reported no remaining FT Vest US Equity Deep Buffer ETF October position as of Q2 2024 after selling out during the quarter.
  • Raymond James & Associates sold 16,654 FT Vest US Equity Deep Buffer ETF October shares in Q2 2024, an estimated $627K.
  • Raymond James & Associates first reported a position in FT Vest US Equity Deep Buffer ETF October in Q4 2022 and held it in 6 quarters.
  • Raymond James & Associates's FT Vest US Equity Deep Buffer ETF October position peaked at $2.61M in Q4 2023.
  • 65 funds tracked by Wall St. Rank held FT Vest US Equity Deep Buffer ETF October as of Q2 2024.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.